HemoSense
This article was originally published in The Gray Sheet
Executive Summary
Blood coagulation and hemostasis monitoring firm expects to introduce the InRatio coagulation monitoring system to the U.S. market in mid-2000. The firm holds several patents for its PT testing technology and plans to file for regulatory clearance in the U.S. and Europe later this year. The device will provide PT measurements at home or in the doctor's office from a fingerstick sample. The worldwide coagulations testing market is expected to exceed $500 mil. by 2004